Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 May;60(5):531–538. doi: 10.1136/jnnp.60.5.531

Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.

M A Hely 1, W G Reid 1, G M Halliday 1, D A McRitchie 1, J Leicester 1, R Joffe 1, W Brooks 1, G A Broe 1, J G Morris 1
PMCID: PMC486366  PMID: 8778258

Abstract

OBJECTIVE--To further elucidate the relation between diffuse Lewy body disease and Parkinson's disease. METHODS AND RESULTS--The clinical features of nine cases of pure diffuse Lewy body disease without pathological evidence of coexisting Alzheimer's neuritic pathology were reported. All patients were aged less than 70 years at onset (mean 62 years). Five patients presented with clinical features, which included assymetric resting tremor had levodopa responsiveness, which were initially indistinguishable from idiopathic Parkinson's disease. All five patients later became demented (mean of three years after presentation). Two further patients presented with parkinsonism and dementia and two patients presented with dementia and developed parkinsonism at a later stage. Hallucinations appeared 2.5-9 years after the onset of symptoms in six patients and were a presenting feature in one patient. All patients met the pathological criteria of idiopathic Parkinson's disease, with respect to the midbrain changes, in addition to having diffuse cortical Lewy bodies. CONCLUSIONS--Diffuse Lewy body disease may present a parkinsonism, dementia, or both depending on whether the Lewy body pathology begins in the midbrain, the cortex, or both together. When it begins in the midbrain, diffuse Lewy body disease is indistinguishable initially from idiopathic Parkinson's disease. Diffuse Lewy body disease may be a common cause of dementia complicating Parkinson's disease.

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong R. A. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia. 1995 May-Jun;6(3):121–125. doi: 10.1159/000106933. [DOI] [PubMed] [Google Scholar]
  2. Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol. 1980 Apr;7(4):329–335. doi: 10.1002/ana.410070408. [DOI] [PubMed] [Google Scholar]
  3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. doi: 10.1007/BF00308809. [DOI] [PubMed] [Google Scholar]
  4. Burkhardt C. R., Filley C. M., Kleinschmidt-DeMasters B. K., de la Monte S., Norenberg M. D., Schneck S. A. Diffuse Lewy body disease and progressive dementia. Neurology. 1988 Oct;38(10):1520–1528. doi: 10.1212/wnl.38.10.1520. [DOI] [PubMed] [Google Scholar]
  5. Byrne E. J., Lennox G., Lowe J., Godwin-Austen R. B. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):709–717. doi: 10.1136/jnnp.52.6.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crowe S. F., Peppard R. F., Borenstein R., Lloyd J. H. Diffuse Lewy body disease and progressive dementia in a young woman. Aust N Z J Psychiatry. 1992 Sep;26(3):507–511. doi: 10.3109/00048679209072078. [DOI] [PubMed] [Google Scholar]
  7. Crystal H. A., Dickson D. W., Lizardi J. E., Davies P., Wolfson L. I. Antemortem diagnosis of diffuse Lewy body disease. Neurology. 1990 Oct;40(10):1523–1528. doi: 10.1212/wnl.40.10.1523. [DOI] [PubMed] [Google Scholar]
  8. Dickson D. W., Ruan D., Crystal H., Mark M. H., Davies P., Kress Y., Yen S. H. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology. 1991 Sep;41(9):1402–1409. doi: 10.1212/wnl.41.9.1402. [DOI] [PubMed] [Google Scholar]
  9. Eggertson D. E., Sima A. A. Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect? Arch Neurol. 1986 May;43(5):524–527. doi: 10.1001/archneur.1986.00520050094034. [DOI] [PubMed] [Google Scholar]
  10. Forno L. S., Barbour P. J., Norville R. L. Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol. 1978 Dec;35(12):818–822. doi: 10.1001/archneur.1978.00500360042008. [DOI] [PubMed] [Google Scholar]
  11. Förstl H., Burns A., Luthert P., Cairns N., Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry. 1993 Mar;162:385–392. doi: 10.1192/bjp.162.3.385. [DOI] [PubMed] [Google Scholar]
  12. Gibb W. R., Esiri M. M., Lees A. J. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain. 1987 Oct;110(Pt 5):1131–1153. doi: 10.1093/brain/110.5.1131. [DOI] [PubMed] [Google Scholar]
  13. Gibb W. R., Mountjoy C. Q., Mann D. M., Lees A. J. A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):701–708. doi: 10.1136/jnnp.52.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Halliday G., Flowers D., Baum L. Analysis of staining methods for different cortical plaques in Alzheimer's disease. Acta Neuropathol. 1994;87(2):174–186. doi: 10.1007/BF00296188. [DOI] [PubMed] [Google Scholar]
  15. Hansen L. A., Masliah E., Galasko D., Terry R. D. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol. 1993 Nov;52(6):648–654. doi: 10.1097/00005072-199311000-00012. [DOI] [PubMed] [Google Scholar]
  16. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M. M., Hofstetter R., Klauber M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990 Jan;40(1):1–8. doi: 10.1212/wnl.40.1.1. [DOI] [PubMed] [Google Scholar]
  17. Hely M. A., Morris J. G., Reid W. G., O'Sullivan D. J., Williamson P. M., Broe G. A., Adena M. A. Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand. 1995 Dec;92(6):455–463. doi: 10.1111/j.1600-0404.1995.tb00480.x. [DOI] [PubMed] [Google Scholar]
  18. Hely M. A., Morris J. G., Reid W. G., O'Sullivan D. J., Williamson P. M., Rail D., Broe G. A., Margrie S. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):903–910. doi: 10.1136/jnnp.57.8.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hughes A. J., Daniel S. E., Blankson S., Lees A. J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993 Feb;50(2):140–148. doi: 10.1001/archneur.1993.00540020018011. [DOI] [PubMed] [Google Scholar]
  20. Ince P., Irving D., MacArthur F., Perry R. H. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci. 1991 Dec;106(2):142–152. doi: 10.1016/0022-510x(91)90251-2. [DOI] [PubMed] [Google Scholar]
  21. Jankovic J., Rajput A. H., Golbe L. I., Goodman J. C. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord. 1993 Oct;8(4):525–532. doi: 10.1002/mds.870080420. [DOI] [PubMed] [Google Scholar]
  22. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch Neurol. 1985 Nov;42(11):1097–1105. doi: 10.1001/archneur.1985.04060100083029. [DOI] [PubMed] [Google Scholar]
  23. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol. 1993;60:456–463. [PubMed] [Google Scholar]
  24. Kuzuhara S., Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol. 1993;60:464–469. [PubMed] [Google Scholar]
  25. Lennox G., Lowe J., Morrell K., Landon M., Mayer R. J. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):67–71. doi: 10.1136/jnnp.52.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lippa C. F., Smith T. W., Swearer J. M. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol. 1994 Jan;35(1):81–88. doi: 10.1002/ana.410350113. [DOI] [PubMed] [Google Scholar]
  27. Louis E. D., Goldman J. E., Powers J. M., Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord. 1995 Mar;10(2):188–194. doi: 10.1002/mds.870100209. [DOI] [PubMed] [Google Scholar]
  28. Mark M. H., Sage J. I., Dickson D. W., Schwarz K. O., Duvoisin R. C. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases. Neurology. 1992 Jul;42(7):1323–1327. doi: 10.1212/wnl.42.7.1323. [DOI] [PubMed] [Google Scholar]
  29. McKeith I. G., Fairbairn A. F., Bothwell R. A., Moore P. B., Ferrier I. N., Thompson P., Perry R. H. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 1994 May;44(5):872–877. doi: 10.1212/wnl.44.5.872. [DOI] [PubMed] [Google Scholar]
  30. McKeith I. G., Fairbairn A. F., Perry R. H., Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry. 1994 Sep;165(3):324–332. doi: 10.1192/bjp.165.3.324. [DOI] [PubMed] [Google Scholar]
  31. McKeith I. G., Perry R. H., Fairbairn A. F., Jabeen S., Perry E. K. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 1992 Nov;22(4):911–922. doi: 10.1017/s0033291700038484. [DOI] [PubMed] [Google Scholar]
  32. McKeith I., Fairbairn A., Perry R., Thompson P., Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992 Sep 19;305(6855):673–678. doi: 10.1136/bmj.305.6855.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. OKAZAKI H., LIPKIN L. E., ARONSON S. M. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol. 1961 Apr;20:237–244. doi: 10.1097/00005072-196104000-00007. [DOI] [PubMed] [Google Scholar]
  34. Pamphlett R., Morris J., Leicester J. A woman with dementia and parkinsonism unresponsive to levodopa. Med J Aust. 1988 Nov 7;149(9):490–494. doi: 10.5694/j.1326-5377.1988.tb120737.x. [DOI] [PubMed] [Google Scholar]
  35. Perry R. H., Irving D., Blessed G., Fairbairn A., Perry E. K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990 Feb;95(2):119–139. doi: 10.1016/0022-510x(90)90236-g. [DOI] [PubMed] [Google Scholar]
  36. Rosenblum W. I., Ghatak N. R. Lewy bodies in the presence of Alzheimer's disease. Arch Neurol. 1979 Mar;36(3):170–171. doi: 10.1001/archneur.1979.00500390088011. [DOI] [PubMed] [Google Scholar]
  37. Starkstein S. E., Preziosi T. J., Bolduc P. L., Robinson R. G. Depression in Parkinson's disease. J Nerv Ment Dis. 1990 Jan;178(1):27–31. doi: 10.1097/00005053-199001000-00005. [DOI] [PubMed] [Google Scholar]
  38. Stern Y., Mayeux R., Sano M., Hauser W. A., Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987 Oct;37(10):1649–1653. doi: 10.1212/wnl.37.10.1649. [DOI] [PubMed] [Google Scholar]
  39. Sugiyama H., Hainfellner J. A., Yoshimura M., Budka H. Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol. 1994 Mar-Apr;13(2):55–59. [PubMed] [Google Scholar]
  40. Vermersch P., Delacourte A., Javoy-Agid F., Hauw J. J., Agid Y. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Ann Neurol. 1993 May;33(5):445–450. doi: 10.1002/ana.410330506. [DOI] [PubMed] [Google Scholar]
  41. Wenning G. K., Ben Shlomo Y., Magalhães M., Daniel S. E., Quinn N. P. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994 Aug;117(Pt 4):835–845. doi: 10.1093/brain/117.4.835. [DOI] [PubMed] [Google Scholar]
  42. Yoshimura M. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease. Eur Neurol. 1988;28 (Suppl 1):29–35. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES